Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers

Breast cancer (BC) prognosis in BRCA1 and BRCA2 mutation carriers has been reported contradictorily, and the significance of variables influencing prognosis in sporadic BC is not established in BC patients with hereditary BRCA1/BRCA2 mutations. In this retrospective cohort study, we analyzed the eff...

Full description

Bibliographic Details
Main Authors: Michal Vocka, Martina Zimovjanova, Zuzana Bielcikova, Petra Tesarova, Lubos Petruzelka, Martin Mateju, Ludmila Krizova, Jaroslav Kotlas, Jana Soukupova, Marketa Janatova, Petra Zemankova, Petra Kleiblova, Jan Novotny, Bohuslav Konopasek, Martina Chodacka, Milan Brychta, Marek Sochor, Denisa Smejkalova-Musilova, Vlastimila Cmejlova, Renata Kozevnikovova, Lenka Miskarova, Sona Argalacsova, Lenka Stolarova, Klara Lhotova, Marianna Borecka, Zdenek Kleibl
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
breast cancer
BRCA1
BRCA2
germline mutations
estrogen receptor
survival
Online Access:https://www.mdpi.com/2072-6694/11/6/738

Internet

https://www.mdpi.com/2072-6694/11/6/738

Similar Items